Botulinum Neurotoxin Type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study
Intradetrusor BoNT-A injection appears to be a safe and effective option in treating refractory urinary incontinent children with overactive bladder. We identified cystometric compliance as a predictor of response. Most children necessitate repeated treatments. Further prospective and controlled studies are necessary in order to fully identify predictors and potential of treatment.
Authors
- Konstantinos Kamperis (ORCID: https://orcid.org/0000-0003-0104-4884)
- Anders Breinbjerg (ORCID: https://orcid.org/0000-0002-8408-4381)
- Martin Skott (ORCID: https://orcid.org/0000-0003-2048-4623)
- Nicklas B Hougaard
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1007/s11255-024-04217-z
- Citations
- 4
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 2.14
Funders
- Aarhus Universitetshospital